SWI Editorial Staff2025-10-03T05:05:35-07:00Private companies in focus: Here’s how investors can buy inSWI Editorial Staff2025-10-03T05:05:35-07:00October 3, 2025|
SWI Editorial Staff2025-10-03T05:04:58-07:00Establishment Labs amends credit agreement, secures $25 million term loan By Investing.comSWI Editorial Staff2025-10-03T05:04:58-07:00October 3, 2025|
SWI Editorial Staff2025-10-03T05:04:38-07:00Greenpro Capital completes $130,000 private placement of common stock By Investing.comSWI Editorial Staff2025-10-03T05:04:38-07:00October 3, 2025|
SWI Editorial Staff2025-10-03T05:04:14-07:00Foreign investors eye China one again — but capital controls and policy risks keep them onSWI Editorial Staff2025-10-03T05:04:14-07:00October 3, 2025|
SWI Editorial Staff2025-10-03T05:03:53-07:00Franklin Global Trust reports 4.1% NAV decline in first half By Investing.comSWI Editorial Staff2025-10-03T05:03:53-07:00October 3, 2025|
SWI Editorial Staff2025-10-03T05:03:32-07:00H.C. Wainwright reiterates Buy rating on Perspective Therapeutics stock By Investing.comSWI Editorial Staff2025-10-03T05:03:32-07:00October 3, 2025|